In vivoimaging of neuromelanin in Parkinson's disease using18F-AV-1451 PET

Allan K. Hansen, Karoline Knudsen, Thea P. Lillethorup, Anne M. Landau, Peter Parbo, Tatyana Fedorova, Hélène Audrain, Dirk Bender, Karen Østergaard, David J. Brooks, Per Borghammer
2016 Brain  
PET may be the first radiotracer to reflect the loss of pigmented neurons in the substantia nigra of parkinsonian patients. The magnitude of the nigral signal loss was smaller than the decrease in striatal dopamine transporter signal measured by dopamine transporter SPECT. These findings suggest a more severe loss of striatal nerve terminal function compared with neuronal cell bodies, in accordance with the post-mortem literature.
doi:10.1093/brain/aww098 pmid:27190023 fatcat:pwevgxy5cngvnjleepo46w3rkq